Modular Medical, Inc. director and officer Paul DiPerna filed a Form 4 on November 9, 2026, disclosing the acquisition of an option to purchase 150,000 shares of common stock on October 29, 2026.
Director Michael George Walsh filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,300 ordinary shares of AerCap Holdings N.V. on the NYSE.
Summit Investors GE IX/VC IV (UK), L.P. filed a Form 144 notice with the SEC on November 9, 2026, disclosing a proposed sale of 2,016 shares of Klaviyo, Inc. Series A common stock on the NYSE.
Summit Partners Growth Equity Fund IX-A, L.P. filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,742,281 shares of Klaviyo, Inc. Series A common stock with an aggregate market value of $57,094,290.42.
Director Lim Say Leong filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 9, 2026, disclosing his initial beneficial ownership position in Bradbury Capital Inc.
Summit Partners Growth Equity Fund IX-B, L.P. filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,712,242 shares of Klaviyo, Inc. Series A common stock on the NYSE.
Summit Investors GE IX/VC IV, LLC filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 15,531 shares of Klaviyo, Inc. Series A common stock on the New York Stock Exchange.
KKR & Co. Inc. (NYSE:KKR) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing share counts, registered securities, and business segment details for the alternative asset management firm.
James River Group Holdings, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the quarterly period ended September 30, 2026, and reporting 46,249,038 shares of common stock outstanding as of November 6, 2026.
Summit Partners Co-Invest (Kiwi), LP filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 182,210 shares of Klaviyo, Inc. Series A common stock through Barclays Capital Inc. on NYSE.